Introduction
============

Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in young adults with a prevalence of 0.2%.[@qcz006-B1] When asymmetrical septal hypertrophy leads to left ventricular outflow tract obstruction (LVOTO) with associated systolic anterior motion of the anterior mitral valve leaflet, this confers a diagnosis of the sub-phenotype hypertrophic obstructive cardiomyopathy (HOCM, also known as 'obstructed HCM'), which occurs in around 70% of HCM sufferers.[@qcz006-B1] Alongside contributing to mortality through multiple mechanisms, including heart failure and malignant arrhythmia, LVOTO produces significant morbidity, inducing symptoms of chest pain, breathlessness, exertion intolerance, light-headedness, and syncope.

Management of symptomatic LVOTO is initially pharmacological but interventions are available in the form of surgical septal myectomy or percutaneous alcohol septal ablation, both carrying risks of complication. Failure, intolerance and reluctance with pharmacological and interventional treatment of LVOTO led to interest in the use of right ventricular pacing as an alternative method for gradient reduction and resultant symptomatic improvement.[@qcz006-B2]^,^[@qcz006-B3]

A number of studies, both randomized and observational, have investigated the effect of dual chamber pacing in HOCM. We systematically analysed these to quantify the effect on LVOTO, left ventricular systolic function, symptoms and functional status.

Methods
=======

We carried out a meta-analysis of studies that evaluated right ventricular pacing in HOCM in accordance with PRISMA guidelines.[@qcz006-B4] We prospectively registered this meta-analysis on the PROSPERO international register of systematic reviews (registration number CRD42017062165).[@qcz006-B5]

Search strategy
---------------

We searched PubMed and the Cochrane Central Register of Controlled Trials for any studies \[randomized controlled trials (RCTs), non-RCTs, and uncontrolled observational studies\] published in the English language where adults with HOCM underwent atrial-synchronous right ventricular pacing. Studies were included if prospectively determined clinically relevant outcomes were reported: left ventricular outflow tract gradient (LVOTg), New York Heart Association (NYHA) functional status, left ventricular ejection fraction, exercise duration, and peak oxygen uptake during cardiopulmonary exercise testing. Systematic reviews were examined for references to relevant studies. Any discrepancies were resolved by consensus. The full search strategy is reported in the [Supplementary material online](#sup1){ref-type="supplementary-material"}.

The study protocol was drafted by A.D.A. and revised by all co-authors. Preliminary search and eligibility analysis was performed by K.C. and Y.A. F.d.V. and A.D.A. performed an independent preliminary search.

Inclusion and exclusion criteria
--------------------------------

We considered all studies of right ventricular pacing in HOCM. Studies were eligible if they recruited patients with an elevated gradient (\>30 mmHg).[@qcz006-B1] We excluded case reports, studies of biventricular pacing, or studies where pacing occurred was delivered in combination with other invasive gradient reduction interventions such as septal ablation or myomectomy.

Endpoints
---------

The primary efficacy endpoint was change in gradient (ΔLVOTg). The secondary efficacy outcomes were change in symptomatic and functional status measured by NYHA class, exercise time, or peak oxygen uptake, from baseline to follow-up. Detailed inclusion criteria for endpoints are found in the [Supplementary material online](#sup1){ref-type="supplementary-material"}.

Follow-up
---------

It was anticipated that the search would reveal trials of varying follow-up duration. We prospectively determined that ΔLVOTg would be analysed according to the following groups of mean follow-up durations: immediate (\<12 h), short-term (12 h to 6 months), medium-term (\>6 months to \<2 years), and long-term (\>2 years). This would allow testing for progressive change in LVOTg due to remodelling over time.[@qcz006-B6] Randomized studies were pre-specified to be analysed separately from observational studies with comparison between RCTs and non-randomized studies of similar follow-up duration.

Data extraction and analysis
----------------------------

A.D.A., K.C., W.J.K., and F.d.V. performed data extraction. J.P.H. performed meta-analysis and designed and carried out statistical methodology with contributions from H.Y.J., L.C., D.P.F., Z.I.W., and M.J.S.S. The statistical programming environment R with the metafor package was used for all statistical analysis. Random-effects meta-analyses were performed using the restricted maximum likelihood estimator. For ordinal categorical outcomes (NYHA), Agresti\'s generalized odds ratios (ORs) were first calculated for each trial before meta-analysis.[@qcz006-B7]^,^[@qcz006-B8] Interactions between groups were assessed using a mixed effects meta-analytical model with the variable in question as a moderator. We used the *I*^2^ statistic to assess heterogeneity. Included RCTs were assessed using the Cochrane risk of bias tool.

Results
=======

We identified 604 study reports (flowchart in *Figure [1](#qcz006-F1){ref-type="fig"}*), of which 34 were eligible for inclusion for at least one pre-specified outcome of interest, comprising 1135 patients.[@qcz006-B6]^,^[@qcz006-B9] There were four RCTs,[@qcz006-B20]^,^[@qcz006-B24]^,^[@qcz006-B28]^,^[@qcz006-B31] all blinded crossover trials, and 30 observational studies.[@qcz006-B6]^,^[@qcz006-B9]^,^[@qcz006-B21]^,^[@qcz006-B25]^,^[@qcz006-B29]^,^[@qcz006-B30]^,^[@qcz006-B32] Baseline characteristics are in *Table [1](#qcz006-T1){ref-type="table"}* and design features are in *Table [2](#qcz006-T2){ref-type="table"}*. Most studies reported data at multiple follow-up durations.[@qcz006-B6]^,^[@qcz006-B10]^,^[@qcz006-B11]^,^[@qcz006-B13]^,^[@qcz006-B20]^,^[@qcz006-B23]^,^[@qcz006-B24]^,^[@qcz006-B27]^,^[@qcz006-B31]^,^[@qcz006-B34]^,^[@qcz006-B40] Mean age was 55.5 years and mean baseline unpaced LVOTg was 78.9 mmHg.

![Flow chart for study selection.](qcz006f1){#qcz006-F1}

###### 

Characteristics of included studies---baseline values

  Authors                                                    Year   *N*   Age (years)         Male (%)   Baseline NYHA   Baseline LVEF (%)                           Baseline LVOTg (mmHg)
  ---------------------------------------------------------- ------ ----- ------------------- ---------- --------------- ------------------------------------------- --------------------------------------------
  Javidgonbadi *et al.*[^a^](#tblfn3){ref-type="table-fn"}   2017   88    55 ± 18             48         2.3 ± 0.6       69 (16)                                     64 (66)
  Jurado Román *et al.*                                      2016   82    66 (range 22--88)   38         NA              73 ± 11                                     95 ± 37
  Krejci *et al.*                                            2013   24    50 ± 17             NA         2.7 ± 0.5       70 ± 9                                      82 ± 46
  Lucon *et al.*                                             2013   51    59 ± 14             47         2.7 ± 0.6       64 ± 8                                      79 ± 36
  Yue-Cheng *et al.*                                         2013   37    52 ± 21             54         2.6 ± 0.8       64 ± 12                                     62 ± 11
  Knyshov *et al.*                                           2013   49    38 ± 21             47         1.9 ± 0.8       NA                                          84 ± 15
  Galve *et al.*                                             2010   50    62 ± 11             52         3.1 ± 0.3       76 ± 10                                     86 ± 29
  Minami *et al.*                                            2010   24    52 ± 16             50         NA              NA                                          89 ± 38
  Sandìn *et al.*                                            2009   72    64 ± 14             38         2.6 ± 0.5       67 ± 10                                     87 (IQR 61.5--115.2)
  Binder *et al.*                                            2008   66    67                  41         2.7 ± 0.7       NA                                          66 ± 36
  Topilski *et al.*                                          2006   25    71 ± 12             48         3.2 ± 0.8       NA                                          92 ± 28
  Hozumi *et al*.                                            2006   14    55 ± 16             79         NA              66 ± 6[^b^](#tblfn4){ref-type="table-fn"}   24 ± 12[^b^](#tblfn4){ref-type="table-fn"}
  Megevand *et al*.[^b^](#tblfn4){ref-type="table-fn"}       2005   18    47                  NA         2.4             NA                                          82 ± 35
  Dimitrow *et al*.                                          2004   19    47 ± 16             52         3.2 ± 0.9       NA                                          77 ± 25
  Mickelsen *et al.*                                         2004   11    69 ± 10             82         NA              NA                                          96 ± 21
  Betocchi *et al.*                                          2002   21    45 ± 15             52         3.1 ± 0.4       NA                                          77 ± 37
  Achterberg *et al.*                                        2002   7     52 ± 13             43         3.1 ± 0.5       NA                                          88 ± 13
  Sant'Anna *et al.*                                         1999   9     47 ± 15             33         2.3 ± 0.5       NA                                          92 ± 22
  Park *et al.*                                              1999   10    62 ± 13             50         3.5 ± 0.5       NA                                          83 ± 44
  Sakai *et al.*                                             1999   12    55 ± 8              58         2.3 ± 0.5       NA                                          106 ± 47
  Maron *et al.*                                             1999   44    53 ± 17             46         NA              NA                                          82 ± 33
  Pak *et al.*                                               1998   5     48 ± 10             60         3               81 ± 8                                      67 ± 33
  Simantirakis *et al.*                                      1998   8     56 ± 7              63         NA              NA                                          70 ± 18
  Nishimura *et al.*                                         1997   19    59 ± 13             53         2.9 ± 0.4       NA                                          76 ± 61[^c^](#tblfn5){ref-type="table-fn"}
  Gadler *et al*.                                            1997   22    68 ± 14             27         3 ± 0.6         NA                                          86 ± 40
  Kappenberger *et al.*                                      1997   83    53 (range 32--87)   60         2.6 ± 0.5       NA                                          70 ± 24
  Slade *et al.*                                             1996   52    48 ± 18             61         2.7 ± 0.6       NA                                          78 ± 31
  Nishimura *et al*.^d^                                      1996   21    58 ± 16             50         NA              NA                                          73 ± 45
  Gadler *et al.*                                            1996   22    65 ± 12             47         2.9 ± 0.6       NA                                          96 ± 33
  Fananapazir *et al.*                                       1994   84    49 ± 16             50         3.2 ± 0.5       NA                                          96 ± 41
  McAreavey *et al.*                                         1992   18    48 ± 14             44         3.3 ± 0.5       NA                                          94 ± 47
  Jeanrenaud *et al.*                                        1992   13    56 ± 14             69         NA              NA                                          82 ± 41
  Fananapazir *et al.*                                       1992   44    49 ± 14             50         3.4 ± 0.5       NA                                          64 ± 7
  McDonald *et al.*                                          1988   11    51 ± 15             55         3 ± 0.6         NA                                          43 ± 25

Values for age, NYHA, EF, and LVOTg are mean ± standard deviation unless otherwise stated. Values for male are percentages. NA if not reported.

NYHA, New York Heart Association class; LVEF, left ventricular ejection fraction; LVOTg, left ventricular outflow tract gradient.

LVOTg and LVEF data for this trial are reported as median (interquartile range).

Baseline LVEF and LVOTg in this study is immediately *after* pacing is switched off after period of pacing (rather than prior to pacing initiation as performed in the other studies).

Value reported from echocardiogram; 87 ± 54 on cardiac catheterization.

This study contains the data from the acute haemodynamic protocol of Nishimura *et al*.[@qcz006-B31]

###### 

Characteristics of included studies---study design

  Authors                                                     Year   Study type                                                           Optimal AV delay selection description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Optimal AV delay methods                                      Longest follow-up                             AV delay (ms)
  ----------------------------------------------------------- ------ -------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------- --------------------------------------------- --------------------------------
  Javidgonbadi *et al.*                                       2017   Observational single-arm (retrospective)                             'set under ECG control to ensure abolition of spontaneous conduction and then evaluated by echocardiography to obtain maximal LVOT gradient reduction without deterioration of diastolic filling'                                                                                                                                                                                                                                                                                                                                                                                                                                                        ECGFull captureTTELVOTgMitral filling pattern                 16 ± 8 years                                  NA
  Jurado Román *et al.*                                       2016   Observational single-arm (retrospective)                             'highest LVOTg reduction without excessive shortening of the ventricular filling time, as indicated by the minimal deterioration in the qualitative morphology of the mitral filling pattern on echocardiography'                                                                                                                                                                                                                                                                                                                                                                                                                                        TTELVOTgMitral filling                                        Median 8.5 years (range 1--18 years)          120 ± 16
  Krejci *et al.*                                             2013   Observational signal-arm (retrospective)                             'set under ECG control to ensure full capture stimulation without the presence of spontaneous or fused contractions. In most patients, AV intervals were optimized under echocardiographic control so that LVOTg was reduced, while the stroke volume was not significantly affected'                                                                                                                                                                                                                                                                                                                                                                    ECGFull captureTTELVOTgStroke Volume                          101 ± 49 months                               NA
  Lucon *et al.*                                              2013   Observational single-arm (retrospective)                             'longest interval associated with complete ventricular capture, at rest and during exercise. Radiofrequency modification of the AV junction was performed in patients whose short spontaneous PR interval precluded the complete capture of the ventricles. In patients whose P wave duration was ≥120 ms, a third lead was placed in the coronary sinus and connected to a biatrial DDD pacemaker to resynchronize the atria'                                                                                                                                                                                                                           ECGFull captureRest and exerciseInvasiveAVNAbiatrial pacing   11.5 years (range 0.4--21.8)                  NA
  Yue-Cheng *et al.*                                          2013   Observational single-arm (retrospective)                             'AV delay (was) adjusted to 90--180 ms in order to ensure the ratio of ventricular pacing was more than 98%'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             DeviceFull capture                                            4 years                                       120 ± 21
  Knyshov *et al.*                                            2013   Observational single-arm (retrospective)                             'acute haemodynamic study with the real-time direct measurement of LVOTg during temporary pacing test in AAI, VDD, and DDD modes with different AV delays'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               InvasiveLVOTg[^a^](#tblfn8){ref-type="table-fn"}              68 ± 6.6 months                               Range 45--120 (s), 85--180 (p)
  Galve *et al.*                                              2010   Observational single-arm (prospective)                               'The optimal AV interval was defined as that obtaining a complete ventricular capture both at rest and during exercise'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ECG/deviceFull capture (rest and exercise)                    5 ± 2.9 years                                 NA
  Minami *et al.*                                             2010   Observational single-arm (prospective)                               'producing the lowest LVOTg without compromise of aortic pressure'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       InvasiveLVOTg, Aorta                                          Immediate                                     70 ± 30
  Sandìn *et al.*                                             2009   Observational single-arm (retrospective)                             'method consisted of modifying the AV pacing interval and assessing the appearance of acute changes in the LVOTg, as well as the transmitral filling curves. The curve that achieved the largest gradient decrease without excessive shortening of the filling time was chosen'                                                                                                                                                                                                                                                                                                                                                                          TTELVOTgMitral filling                                        \>1 year[^b^](#tblfn9){ref-type="table-fn"}   NA
  Binder *et al.*                                             2008   Observational single-arm (retrospective)                             Not stated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               NA                                                            3.7 ± 3 years                                 NA
  Topilski *et al.*                                           2006   Observational single-arm (prospective)                               'To determine the optimized AVI, the AVI was set at 50 ms less than the native PR interval and increased in 25-ms steps, with five different AVIs. The AVIs were tested during sinus rhythm (VDD) and atrial pacing rates of 60 and 80 b.p.m. (DDD). At each AVI and heart rate combination, the LVOT gradient was measured. To achieve haemodynamic steady state, 15 min elapsed between pacemaker programming and the measurement of LVOTg. Systolic cuff blood pressure was used as an estimate of peak systolic aortic pressure. The AVI was programmed at the value with minimal LVOTg not associated with systolic arterial pressure reduction.'   TTELVOTgNon-invasive:cuff BP                                  68 ± 34 months                                106 ± 30
  Hozumi *et al.*                                             2006   Observational single-arm (prospective)                               'optimized in individual patients to achieve the lowest LVOTg'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           TTELVOTg                                                      7.4 ± 2.1 years                               120 ± 31
  Megevand *et al.*[^c^](#tblfn10){ref-type="table-fn"}       2005   Observational single-arm (prospective)                               'the longest interval that captured the ventricle and induced the greatest reduction in outflow gradient without compromising haemodynamics (during cardiac catheterization)'                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Invasive LVOTg, haemodynamics                                 4.1 years (range 1--10)                       Median 60
  Dimitrow *et al.*                                           2004   Observational single-arm (prospective)                               'insure fully paced ventricular activation'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ECGFull capture                                               6 months                                      NA
  Mickelsen *et al.*                                          2004   Randomized single-blinded crossover trial                            'DDD with an AV interval at 30 ms (DDD30)'[^d^](#tblfn11){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           DeviceFixed 30 ms                                             1 month                                       30
  Betocchi *et al.*                                           2002   Cohort (prospective non-randomized controlled observational study)   'Italian cohort: AV interval was chosen as the one associated with the smallest gradient without a decrease in systolic blood pressure. UK cohort: AV interval was chosen as the one associated with the largest width of the QRS complex on the electrocardiograms'                                                                                                                                                                                                                                                                                                                                                                                     TTELVOTgBPECGFull capture                                     1 year                                        89 ± 16
  Achterberg *et al.*                                         2002   Observational single-arm (prospective)                               'programmed between 50 ms and 100 ms to ensure continuous ventricular capture'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           DeviceFixed 50--100ms                                         2.3 ± 1.1 years                               50--100
  Sant'Anna *et al.*                                          1999   Observational single-arm (prospective)                               'lowest LVOTg'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           TTELVOTg                                                      6 months                                      NA
  Park *et al.*                                               1999   Observational single-arm (prospective)                               'echocardiographic guidance to obtain maximal reduction in LVOTg'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        TTELVOTg                                                      12 ± 11 months                                82 ± 17 (s), 93 ± 19 (p)
  Sakai *et al.*                                              1999   Observational single-arm (prospective)                               'produced the minimum LVOTg'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             InvasiveLVOTg, Aorta                                          1 year                                        NA
  Maron *et al.*                                              1999   Randomized double-blinded crossover trial                            'longest interval which captured the ventricle and induced greatest reduction in LVOTg without compromising haemodynamics (i.e. decreasing blood pressure 30 mmHg), after testing a range of AV intervals'                                                                                                                                                                                                                                                                                                                                                                                                                                               InvasiveLVOTg                                                 1 year[^g^](#tblfn14){ref-type="table-fn"}    85 ± 35 (s)
  Pak *et al.*                                                1998   Observational single-arm (prospective)                               'longest value that still yielded optimal ventricular pre-excitation as judged by QRS duration'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          ECGFull capture                                               Immediate                                     NA
  Simantirakis *et al.*                                       1998   Observational single-arm (prospective)                               'longest AV delay that produced a QRS complex of the same width as that seen in VVI pacing'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ECGFull capture                                               1 year                                        80 ± 23 (s)
  Nishimura *et al.*                                          1997   Randomized double-blinded crossover trial                            'producing the lowest left ventricular outflow tract gradient without a significant decrease in aortic pressure or increase in left atrial pressure'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     InvasiveLVOTg, BP, LAP                                        3 months                                      71 ± 21
  Gadler *et al.*                                             1997   Observational single-arm (prospective)                               'most pronounced reduction of left ventricular outflow tract gradient without any decrease in total mitral flow'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         TTELVOTgMitral filling pattern                                12 ± 9 months                                 64 ± 17 (s)
  Kappenberger *et al.*[^e^](#tblfn12){ref-type="table-fn"}   1997   Randomized double-blinded crossover trial                            'full ventricular capture on the ECG without a drop in aortic pressure'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ECGFull captureInvasive                                       3 months                                      61 ± 23 (s)
  Slade *et al.*                                              1996   Observational single-arm (prospective)                               'Shortest sensed AV delay not associated with haemodynamic deterioration, defined as a reduction in mean aortic pressure or cardiac output of \>10%'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     InvasiveBP                                                    11 ± 11 months                                Median 65 (range 25--125) (s)
  Nishimura *et al.*                                          1996   Observational single-arm (prospective)                               'longest AV interval in which there is full ventricular activation by the pacemaker without fusion complexes on the ECG'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 ECGFull capture                                               Immediate                                     NA
  Gadler *et al.*                                             1996   Observational single-arm (prospective)                               'resulting in the greatest reduction of LVOTg without reducing the integral of the A and E waves'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        TTELVOTgMitral filling pattern                                Immediate                                     60--80 (s)
  Fananapazir *et al.*[^f^](#tblfn13){ref-type="table-fn"}    1994   Observational single-arm (prospective)                               'longest interval that permitted ventricular pre-excitation (maximum widening of the QRS complex during the exercise tests)'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ECGFull capture (exercise)                                    2.3 ± 0.8 years                               120 ± 9 (s)
  McAreavey *et al.*                                          1992   Observational single-arm (prospective)                               Not stated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               NA                                                            12 weeks                                      NA
  Jeanrenaud *et al.*                                         1992   Observational single-arm (prospective)                               'best reduction in LVOTg without drop in mean aortic pressure'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           InvasiveLVOTg                                                 44 ± 11                                       63 ± 18
  Fananapazir *et al.*                                        1992   Observational single-arm (prospective)                               'longest AV delay that allowed for maximal pre-excitation (widest-paced QRS duration)'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   ECGFull capture                                               1.5--3 months                                 115 ± 17 (s)
  McDonald *et al.*                                           1988   Observational single-arm (prospective)                               'highest value that maintained ventricular capture at maximum exercise'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ECGFull capture (exercise)                                    1 h                                           90 (range 50--150)

Values are represented as mean ± standard deviation unless otherwise stated. Study type refers to arms of trials fulfilling inclusion criteria. Single-arm studies refer to studies where there is either one arm or where other arms are not control groups with conventional/medical/non-interventional therapy (instead they are alternative therapies). Optimal AV delay selection is the description of optimal AV delay selection in the wording of the source text with changes to wording made only to paraphrase and abbreviate. Optimal AV delay methods refer to the techniques used in determining the optimal AV delay. AV delay refers to the AV delay used in the trial; where the AV delay is specifically stated to be sensed AV delay, this is acknowledged by (s), and where paced (p).

Unclear from publication whether invasive or echocardiographic but wording suggests invasive measurement.

Precise duration of follow-up not stated but longer than 1 year.

Non-responders in initial acute study did not undergo implantation of pacemaker.

This study also included an arm where pacing was optimised to peak aortic flow but LVOTg response to this was not reported for all patients (only for responders and non-responders).

Long-term follow-up data.

Long-term follow-up of Fananapazir *et al.*[@qcz006-B13]

Crossover periods were for 3 months but after the crossover study 6 months of DDD pacing occurred.

Risk of bias
------------

Trial quality for the four RCTs, assessed by the Cochrane risk of bias assessment tool, is shown in *Table [3](#qcz006-T3){ref-type="table"}*. Three were rated as low risk of bias due to double blinding but the fourth was single blinded. Lack of randomization and lack of blinding put all 31 observational studies at risk of bias.

###### 

Risk of bias assessment---randomized controlled trials

  Authors                 Random sequence generation   Allocation concealment   Blinding of participants and personnel   Blinding of outcome assessment   Incomplete outcome data   Selective reporting   Overall quality
  ----------------------- ---------------------------- ------------------------ ---------------------------------------- -------------------------------- ------------------------- --------------------- -----------------
  Kappenberger *et al.*   Low risk                     Low risk                 Low risk                                 Low risk                         Low risk                  Low risk              Low risk
  Nishimura *et al.*      Uncertain                    Uncertain                Low risk                                 Low risk                         Low risk                  Low risk              Low risk
  Maron *et al.*          Uncertain                    Uncertain                Low risk                                 Low risk                         Low risk                  Low risk              Low risk
  Mickelsen *et al.*      Uncertain                    Uncertain                High risk                                High risk                        Low risk                  Low risk              High risk

Left ventricular outflow tract obstruction
------------------------------------------

Thirty-two studies reported mean change in LVOTg (ΔLVOTg) from baseline for at least one follow-up duration. The results are shown in *Figure [2](#qcz006-F2){ref-type="fig"}* for observational studies, *Figure [3](#qcz006-F3){ref-type="fig"}* for RCTs, and summarized in *Table [4](#qcz006-T4){ref-type="table"}*.

![Effect of right ventricular pacing on left ventricular outflow tract gradient at immediate (\<12 h), short-term (12 h to 6 months), medium-term (\>6 months to \<2 years), and long-term (at least 2 years) follow-up in non-randomized studies.](qcz006f2){#qcz006-F2}

![Effect of right ventricular pacing on left ventricular outflow tract gradient at short-term follow-up (1--3 months) in crossover randomized controlled trials.](qcz006f3){#qcz006-F3}

###### 

Results

  Trials (*n*)                                       Patients (*n*)   Study type^a^   Follow-up duration                      Pooled result   95% confidence interval   *P*-value   *I* ^2^ heterogeneity   *P*-value for heterogeneity
  -------------------------------------------------- ---------------- --------------- --------------------------------------- --------------- ------------------------- ----------- ----------------------- -----------------------------
  Percentage change in LVOT gradient from baseline                                                                                                                                                          
   9                                                 234              Obs             Immediate (\<12 h)                      −40.8%          −29.8 to −51.9            \<0.0001    74.9% (high)            \<0.0001
   10                                                243              Obs             Short-term (12 h to 6 months)           −54.3%          −44.1 to −64.6            \<0.0001    39.9% (moderate)        0.12
   11                                                369              Obs             Medium-term (\>6 months to \<2 years)   −51.5%          −44.5 to −58.4            \<0.0001    10.8% (low)             0.3
   16                                                644              Obs             Long-term (at least 2 years)            −66.8%          −56.4 to −77.1            \<0.0001    49.9% (moderate)        0.01
   4                                                 115              RCT             Short-term (1--3 months)                −35%            −23.2 to 46.9             \<0.0001    0% (low)                0.75
  Odds ratio for improved NYHA class from baseline                                                                                                                                                          
   9                                                 388              Obs             All follow-up durations                 8.39            4.39 to 16.04             \<0.0001    74.9% (high)            \<0.0001
   3                                                 137              RCT             All follow-up durations                 1.82            0.96 to 3.44              0.066       81.7% (high)            0.0042

Obs, observational studies (non-randomized); RCT, randomized controlled crossover trials.

In the four RCTs (follow-up ranged from 1 months to 3 months), pacing reduced LVOTg by 35%. The observational studies reported slightly larger LVOTg reductions (*Table [4](#qcz006-T4){ref-type="table"}*).

Meta-regression showed progressively greater gradient reductions at longer follow-up durations, by an average of 5.2% per month \[confidence interval (CI) 2.5--7.9, *P* = 0.0001\].

We, therefore, compared gradient effect size of RCTs with observational studies at similar follow-up times (denoted short-term). The observational studies reported a gradient reduction, which was 18.6% greater than RCTs (CI 1.3--36, *P* = 0.0351).

New York Heart Association status
---------------------------------

As pre-specified, because there were too few studies reporting NYHA, we did not sub-divide them by follow-up duration. The results are displayed in *Figures [4](#qcz006-F4){ref-type="fig"} and [5](#qcz006-F5){ref-type="fig"}* and summarized in *Table [4](#qcz006-T4){ref-type="table"}*.

![Effect of right ventricular pacing on New York Heart Association class at short-term follow-up (1--3 months) in non-randomized studies.](qcz006f4){#qcz006-F4}

![Effect of right ventricular pacing on New York Heart Association class at short-term follow-up (1--3 months) in crossover randomized controlled trials.](qcz006f5){#qcz006-F5}

In RCTs, there was a trend towards improved NYHA class with pacing (OR 1.82, CI 0.96--3.44; *P* = 0.066) but with considerable heterogeneity (*I*^2^ = 81.7%) as a result of one trial showing a particularly prominent favourable effect.

In contrast, almost all of the observational studies (8/9) reported marked improvement in NYHA class giving a combined OR of 8.39 (CI 4.39--16.04, *P* \< 0.0001). This OR is over 450% of the OR for RCTs: ratio of ORs 4.54 (CI 1.61--12.82, *P* = 0.0042).

Exercise and systolic function
------------------------------

For each of the other variables (ejection fraction, exercise duration, and peak oxygen uptake) fewer than five studies reported the data require, and therefore, meta-analysis was not conducted. Reported changes in ejection fraction ranged from +3% to −11%, and in exercise duration from +0.3 min to +3.1 min. There was a single RCT report of peak oxygen uptake change, −0.1 mL/kg/min.

Discussion
==========

This is the first meta-analysis assessing the role of right ventricular pacing as a treatment for LVOTO in HOCM. We found that, in blinded RCTs, pacing reduces LVOTg and shows a non-significant trend to reduce NYHA class. Unblinded observational studies report very much larger symptomatic effects, suggesting an unintentional bias much larger than any genuine effect of the pacing. Echocardiographic gradient assessments, which appear less vulnerable to this bias, suggest a progressive enhancement of the therapeutic effect with the passage of time.

Left ventricular outflow tract gradient reduction
-------------------------------------------------

The meta-analysed RCT data strongly supports the concept that pacing reduces measured LVOTg. There are broadly four mechanisms by which pacing can have an influence. Right ventricular pacing causes incoordination of ventricular activation which may reduce the driving force of ventricular ejection. The altered ventricular activation sequence attenuates the tendency of the left ventricular outflow tract (LVOT) lumen to become very small during systole. Atrioventricular (AV) sequential pacing alters ventricular filling through a change in AV delay, which impacts on ventricular ejection. Finally, knowledge that the patient is receiving a treatment believed to decrease LVOTg may cause an unintended bias of the echocardiographer to try less hard to find a high gradient.

Randomization with allocation concealment ('blinding') is the most effective approach to reduce unintended bias when evaluating therapies. Under blinded conditions each of the trials individually showed that pacing reduced gradient. The measured effect was much larger in the (unblinded) observational studies, −55% rather than −35% (*P* = 0.0351 for difference in study designs). While it is not certain that the much larger effect sizes reported by unblinded studies is due to unintended bias, it is difficult to imagine that the patient groups or procedural characteristics were so markedly different between the two study designs.

Symptoms without blinding
-------------------------

The blinded RCTs showed an encouraging trend towards a statistically significant reduction in NYHA class. A very much larger reduction in NYHA class was reported by the unblinded observational studies. The pooled estimates were so far apart their CIs did not overlap. Indeed, the point estimates for eight out of nine observational studies were for a greater NYHA reduction than even the highest upper limit of the CI of any individual RCT.

We conclude from this that there may be a symptomatic benefit, but that unblinded study design provides no useful information on it. We cannot even use the unblinded symptomatic relief data to compare different studies in order to select pacing approaches for future blinded trials. This is because the great majority of the unblinded symptomatic relief appears to be bias. Therefore, the differences between the unblinded symptom-relief effects reported by different studies will be dominated by differences in the amount of bias rather than clinically meaningful differences in protocol.

The origin of bias in unblinded observational studies investigating subjective outcomes, such as NYHA, may be due to the anticipation of effect by patients. However, the clinicians that rate patients' NYHA status, who are also aware of treatment allocation, may also contribute to bias with their own expectations of successful, or, indeed, unsuccessful, treatment.

Clinical implications
---------------------

Knowing whether AV sequential right ventricular pacing is beneficial in HOCM is important because many patients with HOCM require a defibrillator and the modern era offers two changes from the traditional dual-chamber, transvenous defibrillator. First, omitting the atrial lead can reduce complication rates[@qcz006-B43] but it prevents AV sequential pacing. Second, subcutaneous defibrillators are now available, which are easier to remove than trans-venous defibrillators, but do not have any pacing function.

If AV sequential right ventricular pacing genuinely helps patients, then dual chamber, transvenous defibrillators would be preferable over both single chamber transvenous and subcutaneous defibrillators. Although the blinded RCTs show only a non-significant trend to reduction in NYHA class, the point estimate of the pooled effect size is an OR of 1.82. Roughly speaking, this means patients are twice as likely to feel better with pacing switched on rather than off. This is a potentially meaningful clinical benefit and merits further investigation through further blinded RCTs. Such RCTs need not be expensive or resource-intensive, recruiting patients undergoing *de novo* implantation. They could be conducted in patients who already have a defibrillator, with two randomized periods (pacing on vs. off) and appropriately blinded evaluation. A 2012 Cochrane review[@qcz006-B2] of observational and randomized studies concluded, as we do, that the existing observational studies are of low quality due to inadequate blinding but they did not quantify this effect as we have done. They also call for high quality trials to investigate the potential for a true symptomatic benefit.

The clear evidence of gradient reduction by pacing should not be assumed to prove that symptoms also improve. This is because pacing (i) reduces the force of contraction by inducing incoordination, (ii) reduces the impingement of the LVOT during systole, and (iii) necessarily alters filling since the paced activation must begin before the native activation would have otherwise occurred. The symptomatic effect will therefore be a result of not only changes in LVOT calibre but also ventricular filling and ejection. The choice of AV delay may be important. Applying a very short AV delay almost always reduces stroke volume, even if systolic LVOT calibre is increased. It is unclear how to programme the AV delay of a pacemaker in a patient with HOCM, to provide a net advantage. Each of the studies has taken a different approach, which may have contributed to the lack of translation of gradient reduction to symptomatic benefit, and more work on this is required. The TRICHAMPION trial is underway, which is examining the role of AV nodal ablation, for complete control of AV delay, with biventricular pacing. Importantly, not all symptoms contributing to NYHA status in HCM are due to LVOTO, some maybe due to the cardiomyopathic process itself or comorbidities, and thus unaffected by pacing.

The meta-regression of gradient with respect to follow-up duration suggests a progressive enlargement of the therapeutic effect with longer follow-up across all published data, as has been noted before within single studies.[@qcz006-B34]^,^[@qcz006-B40] It is not yet clear what the mechanism for such a progression might be. One possibility is progressive changes in the structure of the ventricle. However, it should be remembered that long-term right ventricular pacing is known to cause left ventricular function to deteriorate, and therefore, a long-term reduction in gradient should not automatically be assumed to be beneficial.

Limitations
-----------

There were only four RCTs, although all were blinded. Studies mostly did not report lead position or baseline QRS morphology, preventing separate analysis of the apical and septal positions or the presence of pre-existing bundle branch block or meta-regression for these variables. The apical lead position may be expected to result in more dyssynchronous activation and thus greater 'beneficial' LVOTg reduction, but this may be offset, or even superceded, by dyssynchrony-related reduction in myocardial performance. This has importance in procedure technique as achieving an apical lead position in severe hypertrophy can be technically challenging.

Many studies reported the mean baseline (unpaced) and the mean follow-up (paced) LVOTg and NYHA class with a categorical description of the *P*-value (e.g. '*P* \< 0.05') for the statistical test for differences between them. The most useful value, however, would be the mean intra-patient change in LVOTg along with its CI, standard error, standard deviation, or precise *P*-value. This has limited the precision with which we can calculate the CI for the pooled estimate for the change in LVOTg and NYHA, but has not affected the point-estimate.

Conclusions
===========

The blinded RCTs show that AV sequential right ventricular pacing reduces LVOTg in HOCM, and shows a trend to benefit in symptoms that is not statistically significant but of a potentially clinically meaningful size. This may have implications for the choice of defibrillator to implant in HOCM. More research is needed into appropriate selection of AV delay. More blinded RCTs on symptom relief are required and they need not be very demanding or expensive.

Unblinded observational studies report substantially larger gradient reductions and very much larger symptom reductions. The difference between the effect sizes reported by the two study designs (RCT vs. observational) is so large that observational data are of uncertain value in progressing the field. This is particularly so for symptoms, where the unblinded effect sizes appear to be scaled up by 450%.

Supplementary Material
======================

###### 

Click here for additional data file.
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